Skip to Main Content

Paper Details

4-Aminopyridine is a promising treatment option for patients with gain-of-function <i>KCNA2</i>-encephalopathy.
Sci Transl Med
33
2021
Author NameAffiliation
Kathleen M Gorman
Kathleen M GormanUniversity College Dublin
Sanjay M SisodiyaUCL Queen Square Institute of Neurology
Sanjay M Sisodiya
  • 1 - 4

Datasets

Release 1.2